These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 17517527)

  • 1. Expression of cyclooxygenase-2 in canine nasal carcinomas.
    Impellizeri JA; Esplin DG
    Vet J; 2008 Jun; 176(3):408-10. PubMed ID: 17517527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. COX-2 expression and outcome in canine nasal carcinomas treated with hypofractionated radiotherapy.
    Belshaw Z; Constantio-Casas F; Brearley MJ; Dunning MD; Holmes MA; Dobson JM
    Vet Comp Oncol; 2011 Jun; 9(2):141-8. PubMed ID: 21569199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical expression of cyclooxygenase-2 in canine ovarian carcinomas.
    Borzacchiello G; Russo V; Russo M
    J Vet Med A Physiol Pathol Clin Med; 2007 Jun; 54(5):247-9. PubMed ID: 17523957
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cyclooxygenase-2 expression is associated with histologic tumor type in canine mammary carcinoma.
    Heller DA; Clifford CA; Goldschmidt MH; Holt DE; Shofer FS; Smith A; Sorenmo KU
    Vet Pathol; 2005 Nov; 42(6):776-80. PubMed ID: 16301573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of cyclooxygenase-1 and -2 in canine nasal carcinomas.
    Borzacchiello G; Paciello O; Papparella S
    J Comp Pathol; 2004 Jul; 131(1):70-6. PubMed ID: 15144801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of cyclooxygenase-2 in canine epithelial nasal tumors.
    Kleiter M; Malarkey DE; Ruslander DE; Thrall DE
    Vet Radiol Ultrasound; 2004; 45(3):255-60. PubMed ID: 15200266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cox-2 expression in canine mammary carcinomas: correlation with angiogenesis and overall survival.
    Lavalle GE; Bertagnolli AC; Tavares WL; Cassali GD
    Vet Pathol; 2009 Nov; 46(6):1275-80. PubMed ID: 19605908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cohort study of COX-1 and COX-2 expression in canine rectal and bladder tumours.
    Knottenbelt C; Mellor D; Nixon C; Thompson H; Argyle DJ
    J Small Anim Pract; 2006 Apr; 47(4):196-200. PubMed ID: 16573762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of cyclooxygenase-2 by equine ocular and adnexal squamous cell carcinomas.
    Smith KM; Scase TJ; Miller JL; Donaldson D; Sansom J
    Vet Ophthalmol; 2008 Sep; 11 Suppl 1():8-14. PubMed ID: 19046264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Cox-1 and Cox-2 in canine mammary tumours.
    Queiroga FL; Alves A; Pires I; Lopes C
    J Comp Pathol; 2007; 136(2-3):177-85. PubMed ID: 17416236
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An immunohistochemical study of the inflammatory infiltrate associated with nasal carcinoma in dogs and cats.
    Vanherberghen M; Day MJ; Delvaux F; Gabriel A; Clercx C; Peeters D
    J Comp Pathol; 2009 Jul; 141(1):17-26. PubMed ID: 19362315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nasal and paranasal adenocarcinomas with neuroendocrine differentiation in dogs.
    Ninomiya F; Suzuki S; Tanaka H; Hayashi S; Ozaki K; Narama I
    Vet Pathol; 2008 Mar; 45(2):181-7. PubMed ID: 18424830
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of Cox-2 expression in the prognosis of dogs with malignant mammary tumours.
    Queiroga FL; Pires I; Lobo L; Lopes CS
    Res Vet Sci; 2010 Jun; 88(3):441-5. PubMed ID: 19939424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of peroxisome proliferator-activated receptor gamma (PPAR-gamma) in canine nasal carcinomas.
    Paciello O; Borzacchiello G; Varricchio E; Papparella S
    J Vet Med A Physiol Pathol Clin Med; 2007 Oct; 54(8):406-10. PubMed ID: 17877580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COX-2 expression in canine normal and neoplastic mammary gland.
    Dias Pereira P; Lopes CC; Matos AJ; Santos M; Gärtner F; Medeiros R; Lopes C
    J Comp Pathol; 2009 May; 140(4):247-53. PubMed ID: 19203768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cyclooxygenase-2 expression on urothelial and inflammatory cells of cystoscopic biopsies and urine cytology as a possible predictive marker for bladder carcinoma.
    Moussa M; Omran Z; Nosseir M; Lotfy A; Swellam T
    APMIS; 2009 Jan; 117(1):45-52. PubMed ID: 19161536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretreatment tumor prostaglandin E2 concentration and cyclooxygenase-2 expression are not associated with the response of canine naturally occurring invasive urinary bladder cancer to cyclooxygenase inhibitor therapy.
    Mutsaers AJ; Mohammed SI; DeNicola DB; Snyder PW; Glickman NW; Bennett PF; de Gortari AE; Bonney PL; Knapp DW
    Prostaglandins Leukot Essent Fatty Acids; 2005 Mar; 72(3):181-6. PubMed ID: 15664302
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of cyclooxygenase-1 and 2 in naturally-occurring canine cancer.
    Mohammed SI; Khan KN; Sellers RS; Hayek MG; DeNicola DB; Wu L; Bonney PL; Knapp DW
    Prostaglandins Leukot Essent Fatty Acids; 2004 May; 70(5):479-83. PubMed ID: 15062852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination of radiation therapy and firocoxib for the treatment of canine nasal carcinoma.
    Cancedda S; Sabattini S; Bettini G; Leone VF; Laganga P; Rossi F; Terragni R; Gnudi G; Vignoli M
    Vet Radiol Ultrasound; 2015; 56(3):335-43. PubMed ID: 25703137
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of cyclooxygenase-2 expression in canine mast cell tumours.
    Prada J; Queiroga FL; Gregório H; Pires I
    J Comp Pathol; 2012 Jul; 147(1):31-6. PubMed ID: 22079567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.